Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Blumenstein

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Visceral Medicine|November 27, 2019
GLP-2 Analogues as First Specific Treatment of Intestinal FailureIrina Blumenstein
Deutsche Medizinische Wochenschrift (1946)|March 31, 2025
[New and current therapeutic goals of chronic inflammatory bowel disease]Raul Lande, Irina Blumenstein
Innere Medizin (Heidelberg, Germany)|December 14, 2022
[Risankizumab in patients with Crohn's disease]Irina Blumenstein, Sirka Nitschmann
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Sex- and gender-related differences in inflammatory bowel diseasesIrina Blumenstein, Elena Sonnenberg
Visceral Medicine|November 27, 2019
Malnutrition and Intestinal FailureGeorg Lamprecht, Irina Blumenstein
European Journal of Gastroenterology & Hepatology|December 17, 2005
Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot studyOliver Schröder, Irina Blumenstein, Jürgen Stein
World Journal of Gastroenterology|July 16, 2014
Gastroenteric tube feeding: techniques, problems and solutionsIrina Blumenstein, Yogesh M Shastri, Jürgen Stein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitroIrina Blumenstein, Benjamin Keserü, Freya Wolter, et al.
Zeitschrift Fur Gastroenterologie|June 22, 2026
[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care]Irina Blumenstein, Axel Dignass, Torsten Kucharzik, et al.
Zeitschrift Fur Gastroenterologie|January 18, 2018
Screening interval recommendations following a normal colonoscopy in individuals with a familial risk of colorectal cancerJasper Plath, Andrea Siebenhofer, Corina Guethlin, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Visceral Medicine|November 27, 2019
GLP-2 Analogues as First Specific Treatment of Intestinal FailureIrina Blumenstein
Deutsche Medizinische Wochenschrift (1946)|March 31, 2025
[New and current therapeutic goals of chronic inflammatory bowel disease]Raul Lande, Irina Blumenstein
Innere Medizin (Heidelberg, Germany)|December 14, 2022
[Risankizumab in patients with Crohn's disease]Irina Blumenstein, Sirka Nitschmann
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Sex- and gender-related differences in inflammatory bowel diseasesIrina Blumenstein, Elena Sonnenberg
Visceral Medicine|November 27, 2019
Malnutrition and Intestinal FailureGeorg Lamprecht, Irina Blumenstein
European Journal of Gastroenterology & Hepatology|December 17, 2005
Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot studyOliver Schröder, Irina Blumenstein, Jürgen Stein
World Journal of Gastroenterology|July 16, 2014
Gastroenteric tube feeding: techniques, problems and solutionsIrina Blumenstein, Yogesh M Shastri, Jürgen Stein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitroIrina Blumenstein, Benjamin Keserü, Freya Wolter, et al.
Zeitschrift Fur Gastroenterologie|June 22, 2026
[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care]Irina Blumenstein, Axel Dignass, Torsten Kucharzik, et al.
Zeitschrift Fur Gastroenterologie|January 18, 2018
Screening interval recommendations following a normal colonoscopy in individuals with a familial risk of colorectal cancerJasper Plath, Andrea Siebenhofer, Corina Guethlin, et al.
Pageof 7